K. Iran i la proliferació nuclear

Conté: ¿Irán, potencia nuclear?; El reto nuclear de Irán; Dos respuestas al reto nuclear; Con la vista puesta en Irán; La provocación nuclear norcoreana; Irán y la oferta de Obama

Fantaisie en ut mineur, K 475 / Mozart, comp. ; revue et annotée par Lazare-Lévy ; Lazare-Lévy, p

Titre uniforme : [Fantaisies. Piano. KV 475. Do mineur]

Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland.

BACKGROUND: Neuroendocrine neoplasms (NENs) are difficult to diagnose. We used SwissNET data to characterise NEN patients followed in the two academic centres of western Switzerland (WS), and to compare them with patients followed in eastern Switzerland (ES) as well as with international guidelines. METHOD: SwissNET is a prospective database covering data from 522 consecutive patients (285 men, 237 women) from WS (n = 99) and ES (n = 423). RESULTS: Mean ± SD age at diagnosis was 59.0 ± 15.7 years. Overall, 76/522 experienced a functional syndrome, with a median interval of 1.0 (IQR: 1.0-3.0) year between symptoms onset and diagnosis. A total of 51/522 of these tumours were incidental. The primary tumour site was the small intestine (29%), pancreas (21%), appendix (18%) and lung (11%) in both regions combined. In all, 513 functional imaging studies were obtained (139 in WS, 374 in ES). Of these, 381 were 111In-pentetreotide scintigraphies and 20 were 68Ga-DOTATOC PET. First line therapy was surgery in 87% of patients, medical therapy (biotherapy or chemotherapy) in 9% and irradiation in 3% for both regions together. CONCLUSION: Swiss NEN patients appear similar to what has been described in the literature. Imaging by somatostatin receptor scintigraphy (SRS) is widely used in both regions of Switzerland. In good accordance with published guidelines, data on first line therapy demonstrate the crucial role of surgery. The low incidence of biotherapy suggests that long-acting somatostatin analogues are not yet widely used for their anti-proliferative effects. The SwissNET initiative should help improve compliance with ENETS guidelines in the workup and care of NEN patients.

Carte générale de la Turquie d'Europe à la droite du danube ou des beglerbegliks de Roum Jli, Bosna et Morée : dressée d'après les meilleurs observations astronomiques, itinéraires, cartes particulières, & reconnaissances existantes jusqu'à ce jour / par F. Guillaume de Vaudoncourt, ... ; K. Wimberger graviert ; die Gebürge gravirt v. I. Päringer ; In Stein gravirt von A. Falger u:L. Zertahelly in München ; beschrieben und die Gebirge gravirt v. L. Zertahelly

Échelle(s) : [1:1 337 000 environ], Lieues de France, de 25 au degré, 30 [= 9,8 cm]

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

Geographic differences in frequency and azole resistance among Candida glabrata may impact empiric antifungal therapy choice. We examined geographic variation in isolation and azole susceptibility of C. glabrata. We examined 23 305 clinical isolates of C. glabrata during ARTEMIS DISK global surveillance. Susceptibility testing to fluconazole and voriconazole was assessed by disk diffusion, and the results were grouped by geographic location: North America (NA) (2470 isolates), Latin America (LA) (2039), Europe (EU) (12 439), Africa and the Middle East (AME) (728), and Asia-Pacific (AP) (5629). Overall, C. glabrata accounted for 11.6% of 201 653 isolates of Candida and varied as a proportion of all Candida isolated from 7.4% in LA to 21.1% in NA. Decreased susceptibility (S) to fluconazole was observed in all geographic regions and ranged from 62.8% in AME to 76.7% in LA. Variation in fluconazole susceptibility was observed within each region: AP (range, 50-100% S), AME (48-86.9%), EU (44.8-88%), LA (43-92%), and NA (74.5-91.6%). Voriconazole was more active than fluconazole (range, 82.3-84.2% S) with similar regional variation. Among 22 sentinel sites participating in ARTEMIS from 2001 through 2007 (84 140 total isolates, 8163 C. glabrata), the frequency of C. glabrata isolation increased in 14 sites and the frequency of fluconazole resistance (R) increased in 11 sites over the 7-year period of study. The sites with the highest cumulative rates of fluconazole R were in Poland (22% R), the Czech Republic (27% R), Venezuela (27% R), and Greece (33% R). C. glabrata was most often isolated from blood, normally sterile body fluids and urine. There is substantial geographic and institutional variation in both frequency of isolation and azole resistance among C. glabrata. Prompt species identification and fluconazole susceptibility testing are necessary to optimize therapy for invasive candidiasis.

[Archives de la Parole]. , [The king and the margosa seed] : récit en dravidien, telugu, Province de Madras / [Sir George Grierson], éd. ; Linguistic survey of India ; [K. Divakara Rao], voix

[Traditions. Asie. Inde. Présidence de Madras [i.e. Chennai]. Ceded Districts]

[Archives de la Parole]. , [The silly weaver girl] : récit (dravidien, Malayalam, Province de Madras) / [Sir George Grierson], éd. ; Linguistic survey of India ; [C.K. Gopalamenon], voix

[Traditions. Asie. Inde. Présidence de Madras [i.e. Chennai]. Etat du Kerala. Région du Malabar]

[Archives de la Parole]. , La parabole de l'enfant prodigue : dravidien, malayālam, province de Madras / [Sir George Grierson], éd. ; Linguistic survey of India ; [K.K. Achyutan], voix

[Traditions. Asie. Inde. Province de Madras [i.e. Chennai]. État du Kérala. Kochi]

[Archives de la Parole]. , [Song addressed to a maiden] : [in Amindivi MalayāỊam] / [Sir George Grierson], éd. ; Linguistic survey of India ; [Kilaveliyan Muhammad Kōya], voix

[Traditions. Asie. Inde. Province de Madras [i.e. Chennai]. État de Karnataka. Région du Kanara]

[Archives de la Parole]. , Lankātenkā heiken rāvanā : a song in Korku from Melghat (Berar) / [Sir George Grierson], éd. ; Linguistic survey of India ; [Rajotia Kōrkū], voix

[Traditions. Asie. Inde. Etat du Maharashtra. Amravati]